U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H19NO3
Molecular Weight 273.327
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of PIPERLONGUMININE

SMILES

CC(C)CNC(=O)\C=C\C=C\C1=CC2=C(OCO2)C=C1

InChI

InChIKey=WHAAPCGHVWVUEX-GGWOSOGESA-N
InChI=1S/C16H19NO3/c1-12(2)10-17-16(18)6-4-3-5-13-7-8-14-15(9-13)20-11-19-14/h3-9,12H,10-11H2,1-2H3,(H,17,18)/b5-3+,6-4+

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25257731 | https://www.ncbi.nlm.nih.gov/pubmed/24848642 | https://www.ncbi.nlm.nih.gov/pubmed/20381363

Perlonguminine is an alkaloid amide isolated from species of the genus Piper, a plant used in traditional medicine that demonstrates antifungal, anticancer, antihyperlipidemic, and anti-inflammatory properties. Perlonguminine selectively targets a wide spectrum of cancer cells and induce cancer cell death by initiating various pathways, such as apoptosis, necrosis, and autophagy. The elevation of reactive oxygen species (ROS), characteristic of oxidative stress, is an important mechanism by which Perlonguminine promotes cancer-selective cell death. However, the poor aqueous solubility of Perlonguminine is a serious concern for intensive investigations and clinical application.

Originator

Sources: Contributions from Boyce Thompson Institute (1945), 13, 433-42.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
6.31 nM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Rats wer2.4 mg/kg PE by intraperitoneal administration
Route of Administration: Intraperitoneal
SH-SY5Y cells were cultured and maintained in Dulbecco's Modified Eagle Medium (DMEM) solutions (Gibco Laboratories, Grand Island, NY), supplemented with 10% fetal bovine serum (FBS, Gibco Laboratories, Grand Island, NY). Cellswere kept at 37 °C in a humidified 5% CO2/95% O2 incubator. The dissociated cells were seeded in poly-L-lysine-coated plates at a density of 5 × 105/cm2 and cultured in DMEM, supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin. The medium was changed twice weekly. After 8 days of culture, the SH-SY5Y cells were randomly divided into seven groups: normal group (no oxygen–glucose deprivation), oxygen–glucose deprivation group (control group) and oxygen–glucose deprivation +PE groups (2.5, 5, 10, 20 and 40 μM). For oxygen–glucose deprivation, the SH-SY5Y cellswere washed twice in glucose-free balanced salt solution (BSS), and incubated in BSS (no glucose) in a humidified chamber filled with 95% N2/5% CO2 for 3 h at 36.5 °C, while the normal group and PE 20 μM group (no oxygen–glucose deprivation) were filled with 5% CO2/95% O2 and incubated in glucose-free BSS. After oxygen–glucose deprivation, the cultureswere replaced into neurobasalmedium and incubated with PE (2.5, 5, 10, 20 and 40 μM) in a CO2 incubator for 12 h.
Name Type Language
PIPERLONGUMININE
INCI  
INCI  
Official Name English
PIPERLONGUMININ
Common Name English
NSC-125178
Code English
PIPERAMIDE, N-ISOBUTYL-
Common Name English
2,4-PENTADIENAMIDE, 5-(1,3-BENZODIOXOL-5-YL)-N-(2-METHYLPROPYL)-, (2E,4E)-
Systematic Name English
2,4-PENTADIENAMIDE, 5-(1,3-BENZODIOXOL-5-YL)-N-(2-METHYLPROPYL)-, (E,E)-
Systematic Name English
PIPERLONGUMININE [INCI]
Common Name English
N-ISOBUTYLPIPERAMIDE
Common Name English
Code System Code Type Description
WIKIPEDIA
Piperlonguminine
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY
CAS
5950-12-9
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY
NSC
125178
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY
PUBCHEM
5320621
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY
EPA CompTox
DTXSID401021742
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY
FDA UNII
HN39MC8KIO
Created by admin on Sat Dec 16 01:52:52 GMT 2023 , Edited by admin on Sat Dec 16 01:52:52 GMT 2023
PRIMARY